Lower associated costs using rifampicin-miconazole‒impregnated catheters compared with standard catheters - 30/11/11
, María Lecuona, MD, PhD b, María José Ramos, MD b, Alejandro Jiménez, PhD c, María L. Mora, MD, PhD d, Antonio Sierra, MD, PhD e
Address correspondence to Leonardo Lorente, MD, PhD, Department of Critical Care, Hospital Universitario de Canarias, Ofra s/n La Cuesta, La Laguna, 38320 Santa Cruz de Tenerife, Spain.Abstract |
Previous cost-effectiveness analyses found that antibiotic-impregnated catheters decrease the incidence of catheter-related bloodstream infection (CRBSI) as well as the costs related to central venous catheter (CVC) use, including increased hospital length of stay. The effect varied greatly among the studies, however. In this retrospective cohort study, compared with standard catheters, the use of rifampicin-miconazole–impregnated catheters was associated with lower CRBSI incidence and immediate CVC-related costs (taking into account only the costs of CVC, diagnosis, and treatment of CRBSI) (P < .001). Our data indicate that the use of rifampicin-miconazole–impregnated catheters can save associated costs.
Le texte complet de cet article est disponible en PDF.Key Words : Venous, bacteremia, coated, effectiveness, efficiency
Plan
| Conflict of interest: None to report. |
Vol 39 - N° 10
P. 895-897 - décembre 2011 Retour au numéro
Article précédent
- Impact of barrier precautions and antibiotic consumption on the incidence rate of acquired cases of infection or colonization with Acinetobacter baumannii: A 10-year multi-department study
- Annick Lefebvre, Houssein Gbaguidi-Haore, Xavier Bertrand, Michelle Thouverez, Daniel Talon
- Health care-associated infections and visiting policy in an intensive care unit
- Paolo Malacarne, Marzia Corini, Debora Petri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?